BridgeMD
New treatment option for Stomach Cancer
Official title Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type
ClinicalTrials.gov ID: NCT04890171
What this study is testing
- What it's testing
- This multi-center, randomized controlled trial is designed to evaluate clinical effectiveness and cost-effectiveness of ESD for undifferentiated type of EGC meeting the expanded indication compared with surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 75
You may be able to join if
- Patients who are diagnosed with undifferentiated type EGC (signet ring cell carcinoma, poorly differentiated tubular adenocarcinoma, or poorly...
- Adult patients aged 19-75 years
- Patients who had willingness to sign an informed consent form
You likely can't join if
- Patient age: \ 75 years
- Diagnosis and active treatment for other organ cancer except carcinoma in situ and non-melanomatous skin cancer within 5 years
- Previous gastrectomy or esophagectomy history
- Multiple gastric cancers
- Current treatment for serious medical condition which could hinder study participation including severe heart dysfunction, liver cirrhosis, renal...
- Inability to provide an informed consent
See the full eligibility criteria
- Patients who are diagnosed with undifferentiated type EGC (signet ring cell carcinoma, poorly differentiated tubular adenocarcinoma, or poorly cohesive carcinoma) that meets the expanded indication of ESD 1) Tumor...
- Adult patients aged 19-75 years
- Patients who had willingness to sign an informed consent form
- Patient age: \ 75 years
- Diagnosis and active treatment for other organ cancer except carcinoma in situ and non-melanomatous skin cancer within 5 years
- Previous gastrectomy or esophagectomy history
- Multiple gastric cancers
- Current treatment for serious medical condition which could hinder study participation including severe heart dysfunction, liver cirrhosis, renal failure, chronic obstructive pulmonary disease or asthma, or uncontrolled...
- Inability to provide an informed consent
- Inadequate conditions for study enrollment according to the evaluation of study physicians
The study team makes the final eligibility decision.
Where it's taking place
- Goyang-si, Gyeonggi-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Goyang-si, Gyeonggi-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.